EMA consults on risk-based auditing of pharmacovigilance systems, communicating safety info
This article was originally published in Scrip
Executive Summary
The European Medicines Agency is seeking feedback on two draft modules to be included in its good pharmacovigilance practice guideline (GVP). The latest modules pertain to pharmacovigilance audits and communication of safety information.